Literature DB >> 3485687

Purification and characterization of a unique human interleukin 1 from the tumor cell line U937.

P J Knudsen, C A Dinarello, T B Strom.   

Abstract

Interleukin 1 (IL 1) produced by a human tumor cell line was purified to homogeneity by a three-step chromatographic method and was tested in various assays for multiple biologic properties. The purified IL 1 stimulated the proliferative response of the D10.G4.1 cell line, a mouse IL 1 indicator T cell; caused the release of prostaglandin E2 and prostacyclin from cultured human foreskin fibroblasts and from primary human umbilical vein endothelial cells; and elicited characteristic endogenous pyrogen fever in rabbits. To stimulate IL 1 production, the histiocytic lymphoma cell line U937 was incubated with the exotoxin from toxic shock strains of Staphylococcus aureus. Supernatants from stimulated U937 cells were concentrated, and were applied to a reverse-phase HPLC column. IL 1 activity was eluted from the column at high acetonitrile concentration. Subsequent chromatography over hydroxyapatite yielded a single IL 1 species with a pI of 5.5. IL 1 was then purified to homogeneity by gel exclusion HPLC migrating as a 14 kDa species. The molecular size was confirmed by SDS-PAGE and was visualized as a single molecule by silver staining; biologic activity was recovered from the same region of the gel. Limited N-terminal sequence analysis suggested some homology to the pI 7 form of the human blood monocyte IL 1. The pI 5.5 IL 1 produced by U937 cells was only partially neutralized with anti-human monocyte IL 1 antibody, suggesting that U937-derived IL 1 is structurally related to one of the molecularly cloned IL 1 species. IL 1 from stimulated U937 cells possesses the functional characteristics of monocyte IL 1 but may represent a structurally unique IL 1 species, as determined by sequence analysis, size, and antibody reactivity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485687

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Analysis of carrageenan-induced suppression of antibody response.

Authors:  R K Vijayakumar; V R Muthukkaruppan
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

Review 2.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

3.  Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice.

Authors:  Janet Chamberlain; David Evans; Andrea King; Rachael Dewberry; Steven Dower; David Crossman; Sheila Francis
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

4.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.

Authors:  J M Zarling; M Shoyab; H Marquardt; M B Hanson; M N Lioubin; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Normal mouse lung tissue produces a growth-inhibitory factor(s) preferential for mouse monocytic leukemia cells.

Authors:  T Ikuta; Y Honma; J Okabe-Kado; T Kasukabe; M Hozumi
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 6.  Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).

Authors:  G Fantuzzi; C A Dinarello
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.542

7.  TLR4 activation induces IL-1β release via an IPAF dependent but caspase 1/11/8 independent pathway in the lung.

Authors:  Suffwan Eltom; Maria G Belvisi; Liang Yew-Booth; Bilel Dekkak; Sarah A Maher; Eric D Dubuis; Victoria Jones; Kate A Fitzgerald; Mark A Birrell
Journal:  Respir Res       Date:  2014-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.